Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1996 2
1997 2
2000 4
2001 1
2002 4
2003 5
2004 3
2005 3
2006 2
2007 2
2009 2
2010 1
2012 1
2013 4
2014 3
2015 2
2016 4
2017 3
2018 3
2019 3
2020 4
2021 2
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Chronic Myelomonocytic Leukemia"
Page 1
Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.
Patnaik MM, Lasho T. Patnaik MM, et al. Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):460-464. doi: 10.1182/hematology.2020000163. Hematology Am Soc Hematol Educ Program. 2020. PMID: 33275673 Free PMC article. Review.
Myelodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN) overlap syndromes are unique myeloid neoplasms, with overlapping features of MDS and MPN. They consist of four adult onset entities including chronic myelomonocytic leukemia (CMML), MDS/MPN-ring …
Myelodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN) overlap syndromes are unique myeloid neoplasms, with overlapping features o …
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
DiNardo CD, Maiti A, Rausch CR, Pemmaraju N, Naqvi K, Daver NG, Kadia TM, Borthakur G, Ohanian M, Alvarado Y, Issa GC, Montalban-Bravo G, Short NJ, Yilmaz M, Bose P, Jabbour EJ, Takahashi K, Burger JA, Garcia-Manero G, Jain N, Kornblau SM, Thompson PA, Estrov Z, Masarova L, Sasaki K, Verstovsek S, Ferrajoli A, Weirda WG, Wang SA, Konoplev S, Chen Z, Pierce SA, Ning J, Qiao W, Ravandi F, Andreeff M, Welch JS, Kantarjian HM, Konopleva MY. DiNardo CD, et al. Lancet Haematol. 2020 Oct;7(10):e724-e736. doi: 10.1016/S2352-3026(20)30210-6. Epub 2020 Sep 5. Lancet Haematol. 2020. PMID: 32896301 Free PMC article. Clinical Trial.
The study enrolled older patients (aged >60 years) with newly diagnosed AML, not eligible for intensive chemotherapy; secondary AML (progressed after myelodysplastic syndrome or chronic myelomonocytic leukaemia); and relapsed or refractory AML. ...All pati …
The study enrolled older patients (aged >60 years) with newly diagnosed AML, not eligible for intensive chemotherapy; secondary AML (prog …
Chronic myelomonocytic leukemia: myelodysplastic or myeloproliferative?
Itzykson R, Fenaux P, Solary E. Itzykson R, et al. Best Pract Res Clin Haematol. 2013 Dec;26(4):387-400. doi: 10.1016/j.beha.2013.09.006. Epub 2013 Oct 1. Best Pract Res Clin Haematol. 2013. PMID: 24507815 Review.
Chronic myelomonocytic leukemia (CMML) is a clonal disease of the hematopoietic stem cell that provokes a stable increase in peripheral blood monocyte count. ...Inconstant and non-specific cytogenetic aberrations have a negative prognostic impact. Recurren …
Chronic myelomonocytic leukemia (CMML) is a clonal disease of the hematopoietic stem cell that provokes a stable increa …
Emerging drugs for the treatment of chronic myelomonocytic leukemia.
Ramos Perez J, Montalban-Bravo G. Ramos Perez J, et al. Expert Opin Emerg Drugs. 2020 Dec;25(4):515-529. doi: 10.1080/14728214.2020.1854224. Epub 2020 Dec 13. Expert Opin Emerg Drugs. 2020. PMID: 33280448 Review.
Introduction: Chronic myelomonocytic leukemia (CMML) is a clonal hematologic disorder with heterogenous prognosis, but with no curative therapies with exception of allogeneic transplant. ...Areas covered: The current article reviews the most relevant emerging …
Introduction: Chronic myelomonocytic leukemia (CMML) is a clonal hematologic disorder with heterogenous prognosis, but …
Eosinophilia in Hematologic Disorders.
Falchi L, Verstovsek S. Falchi L, et al. Immunol Allergy Clin North Am. 2015 Aug;35(3):439-52. doi: 10.1016/j.iac.2015.04.004. Immunol Allergy Clin North Am. 2015. PMID: 26209894 Free PMC article. Review.
There are 3 main types of eosinophilia-associated myeloid neoplasms (MN-eos): myeloid and lymphoid neoplasms, chronic eosinophilic leukemia not otherwise specified, and idiopathic hypereosinophilic syndrome (HES). Imatinib mesylate has revolutionized the treatment o …
There are 3 main types of eosinophilia-associated myeloid neoplasms (MN-eos): myeloid and lymphoid neoplasms, chronic eosinophilic …
Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial.
Schroeder T, Stelljes M, Christopeit M, Esseling E, Scheid C, Mikesch JH, Rautenberg C, Jäger P, Cadeddu RP, Drusenheimer N, Holtick U, Klein S, Trenschel R, Haas R, Germing U, Kröger N, Kobbe G. Schroeder T, et al. Haematologica. 2023 Nov 1;108(11):3001-3010. doi: 10.3324/haematol.2022.282570. Haematologica. 2023. PMID: 37259567 Free PMC article.
We, therefore, prospectively investigated tolerability and efficacy of this combination as first salvage therapy for adults with post-transplant relapse of acute myeloid leukemia, myelodysplastic syndromes and chronic myelomonocytic leukemia. ...Fifty …
We, therefore, prospectively investigated tolerability and efficacy of this combination as first salvage therapy for adults with post-transp …
Curcumol and FTY720 synergistically induce apoptosis and differentiation in chronic myelomonocytic leukemia via multiple signaling pathways.
Zhao M, Yang C, Chai S, Yuan Y, Zhang J, Cao P, Wang Y, Xiao X, Wu K, Yan H, Liu J, Sun S. Zhao M, et al. Phytother Res. 2021 Apr;35(4):2157-2170. doi: 10.1002/ptr.6968. Epub 2020 Dec 4. Phytother Res. 2021. PMID: 33274566
Chronic myelomonocytic leukemia (CML) is a myeloid tumor characterized by MDS (myelodysplastic syndrome) and MPN (myeloproliferative neoplasms). ...Tyrosine kinase inhibitors (TKIs) are also a treatment option, and patients are currently recommended to take t …
Chronic myelomonocytic leukemia (CML) is a myeloid tumor characterized by MDS (myelodysplastic syndrome) and MPN (myelo …
Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review.
Grignano E, Mekinian A, Braun T, Liozon E, Hamidou M, Decaux O, Puéchal X, Kahn JE, Schoindre Y, Rossignol J, Lortholary O, Lioger B, Hermine O, Park S, Ades L, Montestruc F, Ricard L, Gardin C, Fenaux P, Fain O; GFM, SNFMI and CRI. Grignano E, et al. Leuk Res. 2016 Aug;47:136-41. doi: 10.1016/j.leukres.2016.05.013. Epub 2016 Jun 2. Leuk Res. 2016. PMID: 27337291 Free article.
We wanted to describe the characteristics, treatment and outcome of autoimmune and inflammatory diseases (SAIDs) associated with chronic myelomonocytic leukemia (CMML), and conducted a French multicenter retrospective study and a literature review. ...Hence, …
We wanted to describe the characteristics, treatment and outcome of autoimmune and inflammatory diseases (SAIDs) associated with chronic …
Eosinophil-rich tissue infiltrates in chronic myelomonocytic leukemia patients.
Droin N, Lucas N, Parinet V, Selimoglu-Buet D, Humbert M, Saada V, Lambotte O, Solary E, Noël N. Droin N, et al. Leuk Lymphoma. 2017 Dec;58(12):2875-2879. doi: 10.1080/10428194.2017.1330468. Epub 2017 Jun 8. Leuk Lymphoma. 2017. PMID: 28593791
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder that associates dysplastic and proliferative features. ...Whole exome sequencing of leukemic cells did not identify a recurrent genetic abnormality among these three patients who …
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder that associates dysplastic and proliferative …
Azacitidine for Relapse After Allogeneic Stem Cell Transplantation-Single-Center Study.
Karakulska-Prystupiuk E, Drozd-Sokołowska J, Waszczuk-Gajda A, Stefaniak A, Dwilewicz-Trojaczek J, Kulikowska A, Chmarzyńska-Mróz E, Basak G, Paluszewska M, Boguradzki P, Jędrzejczak W. Karakulska-Prystupiuk E, et al. Transplant Proc. 2018 Sep;50(7):2212-2217. doi: 10.1016/j.transproceed.2018.02.148. Epub 2018 Mar 14. Transplant Proc. 2018. PMID: 30177138
Of 28 evaluated patients, 18 were males, and the median age was 60 years (range, 15-78). There were 15 patients with acute myeloid leukemia, 8 with myelodysplastic syndrome, 4 with chronic myelomonocytic leukemia, and 1 with primary myelofibrosis. ...
Of 28 evaluated patients, 18 were males, and the median age was 60 years (range, 15-78). There were 15 patients with acute myeloid leukem …
61 results